Aton Ra Partners Arvinas, Inc. Transaction History

Aton Ra Partners

  • $50.1 Million
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023
SELL
$26.15 - $37.26 $29,209 - $41,619
-1,117 Reduced 13.63%
7,080 $193,000
Q4 2022

Feb 02, 2023
SELL
$32.47 - $57.24 $71,985 - $126,901
-2,217 Reduced 21.29%
8,197 $280,000
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $4,773 - $6,610
114 Added 1.11%
10,414 $463,000
Q2 2022

Aug 15, 2022
BUY
$36.01 - $74.24 $370,903 - $764,672
10,300 New
10,300 $434,000

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
70.9M
Call Options Held
1.52M
Put Options Held
346K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $986M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email